Упрощенная HTML-версия
300.
Impact of high-normal blood pressure on the risk of cardiovascular disease /
R.S. Vasan [et al.] // N. Engl. J. Med. – 2001. – Vol. 345, № 18. – P. 1291-
1297.
301.
Impaired glucose tolerance, Type II diabetes mellitus and carotid
atherosclerosis: prospective results from the Bruneck Study / E. Bonora [et al.]
// Diabetologia. – 2000. – Vol. 43. – P. 156-164.
302.
Impaired transport of leptin across the blood-brain barrier in obesity is acquired
and reversible / W.A. Banks [et al.] // Am J Physiol Endocrinol Metab. – 2003.
– Vol. 285. – P. 10-15.
303.
Increased platelet aggregation and intracellular calcium in hypertensive
patients: effect of cyclooxygenase blockade / C. Lechi [et al.] // J. Human
Hypertens. – 1989. – Vol. 7. – P. 160-161.
304.
Increasing prevalence of overweight among US adults. The National Health
and Nutrition Examination Surveys, 1960 to 1991 / R. J. Kuczmarski [et al.] //
JAMA. – 1994. – Vol. 272. – P. 205–211.
305.
Insulin resistance syndrome predicts the risk of coronary heart disease and
stroke in healthy mid dle-aged men / M. Pyorala [et al.] // Arterioscler Thromb
Vase Biol. – 2000. – Vol. 20. – P. 538-544.
306.
Interactions between leptin and the human sympathetic nervous system / N.
Eikelis [et al.] // Hypertension. – 2003. – Vol. 41. – P. 1072-1079.
307.
Intracerebroventricular leptin increases lumbar and renal sympathetic nerve
activity and blood pressure in normal rats / J. C. Dunbar [et al.] // Diabetes. –
1997. – Vol. 46. – P. 2040-2043.
308.
Islam K. N. α-tocopherol enrichment of monocytes decreases agonist-induced
adhesion to human endothelial cell / K. N. Islam, S. Devaraj, I. Jialal //
Circulation. – 1998. – № 21. – P. 2255-2261.
309.
Itil T. M. Quantitative EEG as biological marker / T. M. Itil, P. Le Bars, E.
Eralp // Neuropsychopharmac. – 1994. – Vol. 10. – P. 310.